1. Home
  2. IMKTA vs DMRA Comparison

IMKTA vs DMRA Comparison

Compare IMKTA & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

N/A

Current Price

$84.72

Market Cap

1.6B

ML Signal

N/A

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$20.23

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IMKTA
DMRA
Founded
1963
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
IMKTA
DMRA
Price
$84.72
$20.23
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $46.89
AVG Volume (30 Days)
68.2K
★ 607.7K
Earning Date
08-06-2026
11-05-2026
Dividend Yield
★ 0.78%
N/A
EPS Growth
N/A
★ 121.48
EPS
★ N/A
N/A
Revenue
★ $5,334,032,609.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.91
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$67.17
$16.50
52 Week High
$95.62
$34.89

Technical Indicators

Market Signals
Indicator
IMKTA
DMRA
Relative Strength Index (RSI) 47.79 31.99
Support Level $82.32 $18.99
Resistance Level $84.55 $26.76
Average True Range (ATR) 1.53 1.59
MACD 0.34 -0.18
Stochastic Oscillator 43.04 15.83

Price Performance

Historical Comparison
IMKTA
DMRA

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: